← Back to All Filings

Lilly Endowment Sells $259M of Eli Lilly (LLY) Stock

Low SignificanceNovember 3, 2025 at 4:02:00 PM EST

ELI LILLY & Co

$LLY4CIK: 0000059478

Subscribe to track LLY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Lilly Endowment Sells $259M of Eli Lilly (LLY) Stock

Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: LILLY ENDOWMENT INC Title: null | Relationship: Ten Percent Owner

Transaction: • Type: Sell • Shares: 291,342 • Avg Price: $889.61 • Value: $259,179,145 • Owned After: 94,231,978

Key Insight: Despite the large dollar value, this sale represents a very small fraction (0.03%) of the company's market cap and a minor reduction (0.31%) in the Endowment's substantial holdings.

Market Context: This appears to be a routine portfolio management transaction by the foundation, not a significant signal on the company's outlook.

Comprehensive Analysis

SEC Filing Analysis: ELI LILLY & Co (LLY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Lilly Endowment Inc., a foundational 10%+ owner, executed a large-value sale of $259 million, which is immaterial relative to Eli Lilly's mega-cap status and the Endowment's total holdings.
  • Market Impact: The transaction is unlikely to have a significant market impact due to its small size relative to the company's market capitalization and public float.

Company Information

FieldValue
CompanyELI LILLY & Co
Ticker SymbolLLY
CIK0000059478
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameLILLY ENDOWMENT INC
CIK0000316011
Title/Positionnull
RelationshipTen Percent Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved291,342 (aggregated from 8 transactions)
Price Per Share$889.61 (Weighted Average)
Total Value$259,179,145
Shares Owned After94,231,978
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$259,179,145
% of Market Cap0.034%
Shares Transacted291,342
% of Shares Outstanding0.031%
Post-Transaction Ownership94,231,978 shares (9.96% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company with a market capitalization of $772.28 billion, a $259 million transaction is considered routine and not financially material.
  • Ownership Concentration: The sale was a minor reduction of the Endowment's position, trimming only 0.31% of its prior holdings. The Endowment remains a significant shareholder with approximately 9.96% of shares outstanding post-transaction.
  • Transaction Significance: The sale falls well below the thresholds for moderate or high significance. Such sales by large foundations are often conducted for liquidity, diversification, or to fund philanthropic obligations, rather than as a commentary on the underlying company's performance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is too small relative to the company's size and the insider's total holdings to signal a change in sentiment. It is likely to be absorbed by the market with minimal price impact.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is a fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. The market generally understands that large foundations like Lilly Endowment periodically sell shares for operational purposes.

Additional Context

Transaction Notes

  • Special Circumstances: The sale was executed across eight separate transactions on the same day at weighted average prices, as detailed in the filing's footnotes. This is a common practice for large block sales to minimize market impact.
Topics:#SECFiling#InsiderTrading#LLY#EliLilly#Form4#InsiderSell#StockMarket#Pharma#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.